The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the BioPharma Credit PLC stock forecast from 0 analysts, the average analyst target price for BioPharma Credit PLC is not available over the next 12 months. BioPharma Credit PLC’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BioPharma Credit PLC is Bullish , which is based on 5 positive signals and 2 negative signals. At the last closing, BioPharma Credit PLC’s stock price was USD 0.874. BioPharma Credit PLC’s stock price has changed by +0.23% over the past week, +4.55% over the past month and +2.34% over the last year.
No recent analyst target price found for BioPharma Credit PLC
No recent average analyst rating found for BioPharma Credit PLC
Company Overview BioPharma Credit PLC
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom. Read Less
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Lond...Read More
Frequently Asked Questions About BioPharma Credit PLC (BPCR:LSE) Stock
Stock Target Advisor's fundamental analysis for BioPharma Credit PLC's stock is Bullish .
BPCR:LSE stock's dividend yield is 8.20%.
Our analysis grades BPCR:LSE stock's dividend yield at B. This means that BPCR:LSE stock's dividend yield is above 84% of the stocks in the Asset Management sector in the LSE exchange.
Based on this BPCR:LSE may be a good dividend stock for its sector.
Unfortunately we do not have enough data on BPCR:LSE's stock to indicate what its average analyst target is.
BPCR:LSE stock's Price/Earning ratio is 0.11.
Our analysis grades BPCR:LSE stock's Price / Earning ratio at A+. This means that BPCR:LSE stock's Price/Earning ratio is above 3.000000000000003% of the stocks in the Asset Management sector in the LSE exchange.
Based on this BPCR:LSE may be undervalued for its sector.
The last closing price of BPCR:LSE's stock was USD 0.87.
The most recent market capitalization for BPCR:LSE is USD 106.06B.
Unfortunately we do not have enough analyst data on BPCR:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains BioPharma Credit PLC's stock.
As per our most recent records BioPharma Credit PLC has 0 Employees.
BioPharma Credit PLC's registered address is 65 Gresham Street, London, United Kingdom, EC2V 7NQ.
You can get more information about it from BioPharma Credit PLC's website at https://www.bpcruk.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BPCR:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
